{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:29:49Z","timestamp":1790281789684,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.autrev.2018.09.004","type":"journal-article","created":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T22:11:49Z","timestamp":1545084709000},"page":"199-202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Novel Sj\u00f6gren's autoantibodies found in fibromyalgia patients with sicca and\/or xerostomia"],"prefix":"10.1016","volume":"18","author":[{"given":"Eliana","family":"Applbaum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Lichtbroun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2018.09.004_bb0005","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1001\/jama.1987.03390200122026","article-title":"Fibromyalgia syndrome. An emerging but controversial condition","volume":"257","author":"Goldenberg","year":"1987","journal-title":"JAMA"},{"key":"10.1016\/j.autrev.2018.09.004_bb0010","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1001\/jama.2014.3266","article-title":"Fibromyalgia: a clinical review","volume":"311","author":"Clauw","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.autrev.2018.09.004_bb0015","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/art.38905","article-title":"The prevalence of fibromyalgia in the general population: a comparison of the American College of Rheumatology 1990, 2010, and modified 2010 classification criteria","volume":"67","author":"Jones","year":"2015","journal-title":"Arthritis Rhematol"},{"key":"10.1016\/j.autrev.2018.09.004_bb0020","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/art.1780330203","article-title":"The American College of rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee","volume":"33","author":"Wolfe","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.09.004_bb0025","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/acr.20140","article-title":"The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity","volume":"62","author":"Wolfe","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.autrev.2018.09.004_bb0030","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1093\/ije\/dyi265","article-title":"The epidemiology of chronic syndromes that are frequently unexplained: do they have common associated factors?","volume":"35","author":"Aggarwal","year":"2006","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.autrev.2018.09.004_bb0035","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.nicl.2016.01.021","article-title":"Characterizing \u201cfibrofog\u201d: Subjective appraisal, objective performance, and task- related brain activity during a working memory task","volume":"11","author":"Walitt","year":"2016","journal-title":"Neuroimage Clin"},{"key":"10.1016\/j.autrev.2018.09.004_bb0040","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s10194-011-0377-6","article-title":"Clinical features of headache patients with fibromyalgia comorbidity","volume":"12","author":"de Tommaso","year":"2011","journal-title":"J Headache Pain"},{"key":"10.1016\/j.autrev.2018.09.004_bb0045","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s10067-013-2218-2","article-title":"The prevalence of fibromyalgia and its relation with headache characteristics in episodic migraine","volume":"32","author":"Kucuksen","year":"2013","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2018.09.004_bb0050","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/mus.24156","article-title":"Small nerve fiber involvement in patients referred for fibromyalgia","volume":"49","author":"Giannoccaro","year":"2014","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.autrev.2018.09.004_bb0055","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1097\/ICO.0b013e318285c912","article-title":"Dry eye in patients with fibromyalgia and its relevance to functional and emotional status","volume":"32","author":"T\u00fcrkyilmaz","year":"2013","journal-title":"Cornea"},{"key":"10.1016\/j.autrev.2018.09.004_bb0060","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s12016-015-8509-4","article-title":"Fibromyalgia: a critical and Comprehensive Review","volume":"49","author":"Borchers","year":"2015","journal-title":"Clinic Rev Allerg Immunol"},{"key":"10.1016\/j.autrev.2018.09.004_bb0065","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/03009742.2015.1052553","article-title":"Association of rheumatic diseases with symptom severity, quality of life, and treatment outcome in patients with fibromyalgia","volume":"45","author":"Jiao","year":"2016","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2018.09.004_bb0070","series-title":"Differential diagnosis of fibromyalgia","author":"Goldenberg","year":"2017"},{"issue":"4","key":"10.1016\/j.autrev.2018.09.004_bb0075","doi-asserted-by":"crossref","first-page":"R134","DOI":"10.1186\/ar3072","article-title":"Localized 1H-NMR spectroscopy in patients with fibromyalgia: a controlled study of changes in cerebral glutamate\/glutamine, inositol, choline, and N-acetylaspartate","volume":"12","author":"Fayed","year":"2010","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.autrev.2018.09.004_bb0080","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jpain.2008.07.003","article-title":"Hippocampal metabolite abnormalities in fibromyalgia: correlation with clinical features","volume":"10","author":"Wood","year":"2009","journal-title":"J Pain"},{"key":"10.1016\/j.autrev.2018.09.004_bb0085","first-page":"741","article-title":"Dysfunctional neurotransmitter systems in fibromalgia, their role in central stress circuitry and pharmacological actions on these systems","volume":"2012","author":"Becker","year":"2012","journal-title":"Pain Res Treat"},{"issue":"7","key":"10.1016\/j.autrev.2018.09.004_bb0090","first-page":"1564","article-title":"Increased concentrations of nerve growth factor in cerebrospinal fluid of patients with fibromyalgia","volume":"26","author":"Giovengo","year":"1999","journal-title":"J Rheumatol"},{"issue":"9","key":"10.1016\/j.autrev.2018.09.004_bb0095","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1210\/jc.2010-0061","article-title":"High prevalence of growth hormone deficiency in severe fibromyalgia syndromes","volume":"96","author":"Cuatrecasas","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.autrev.2018.09.004_bb0100","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ghir.2006.12.006","article-title":"Is further evaluation for growth hormone (GH) deficiency necessary in fibromyalgia patients with low serum insulin-like growth factor (IGF-1) levels?","volume":"17","author":"Yuen","year":"2007","journal-title":"Growth Horm IGF Res"},{"key":"10.1016\/j.autrev.2018.09.004_bb0105","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00002060-199705000-00014","article-title":"Immunologic profile of patients with fibromyalgia","volume":"76","author":"Smart","year":"1997","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1016\/j.autrev.2018.09.004_bb0110","first-page":"12","article-title":"Coexistence of fibromyalgia syndrome (FS) and systemic lupus erythematosus (SLE)","volume":"21","author":"Romano","year":"1992","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2018.09.004_bb0115","first-page":"1202","article-title":"Fibromyalgia in human immunodeficiency virus infection","volume":"17","author":"Buskila","year":"1990","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2018.09.004_bb0120","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s10067-017-3556-2","article-title":"Fibromyalgia in patients with thyroid autoimmunity: prevalence and relationship with disease activity","volume":"36","author":"Haliloglu","year":"2017","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2018.09.004_bb0125","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","article-title":"And the International Sjogren's syndrome criteria working group. 2016 ACR\/EULAR classification criteria for primary Sj\u00f6gren's syndrome: a consensus and data-driven methodology involving three international patient cohorts","volume":"76","author":"Shiboski","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2018.09.004_bb0130","series-title":"Pathogenesis of Sjogren's syndrome","author":"Fox","year":"2017"},{"key":"10.1016\/j.autrev.2018.09.004_bb0135","series-title":"Autoimmune diseases of the skin","first-page":"261","article-title":"Sjogren's syndrome","author":"Fox","year":"2005"},{"key":"10.1016\/j.autrev.2018.09.004_bb0140","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.semarthrit.2007.06.002","article-title":"Primary Sjogren's syndrome: current and prospective therapies","volume":"37","author":"Thanou-Stavraki","year":"2008","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.09.004_bb0145","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.clim.2012.09.013","article-title":"Novel autoantibodies in Sjogren's syndrome","volume":"145","author":"Shen","year":"2012","journal-title":"Clin Immunol (Orlando, Fla)"},{"issue":"6 Suppl 74","key":"10.1016\/j.autrev.2018.09.004_bb0150","first-page":"117","article-title":"Fatigue and widespread pain in systemic lupus erythematosus and Sj\u00f6gren's syndrome: symptoms of the inflammatory disease or associated fibromyalgia?","volume":"30","author":"Iannuccelli","year":"2012","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2018.09.004_bb0155","first-page":"133","article-title":"An association of fibromyalgia with primary Sj\u00f6gren's syndrome: a prospective study of 72 patients","volume":"22","author":"Bonafede","year":"1995","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2018.09.004_bb0160","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1297-319X(01)00341-4","article-title":"Fibromyalgia in Italian patients with primary Sj\u00f6gren's syndrome","volume":"69","author":"Ostuni","year":"2002","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.autrev.2018.09.004_bb0165","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.autrev.2018.01.009","article-title":"Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome \u2013 evidence for an autoimmune disease","volume":"17","author":"Sotzny","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.09.004_bb0170","first-page":"24","article-title":"Comorbidclinical conditions in chronic fatigue: a co-twin control study","volume":"16","author":"Aaron","year":"2001","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.autrev.2018.09.004_bb0175","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/rheumatology\/40.7.806","article-title":"Autoantibodies to a 68\/48 kDa protein in chronic fatigue syndrome and primary fibromyalgia: a possible marker for hypersomnia and cognitive disorders","volume":"40","author":"Nishikai","year":"2001","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2018.09.004_bb0180","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1172\/JCI118990","article-title":"Autoanti-bodies to nuclear envelope antigens in chronic fatigue syndrome","volume":"98","author":"Konstantinov","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2018.09.004_bb0185","doi-asserted-by":"crossref","first-page":"e51515","DOI":"10.1371\/journal.pone.0051515","article-title":"Reductionof [11C](+)3-MPB binding in brain of chronic fatigue syndrome with serum auto-antibody against muscarinic cholinergic receptor","volume":"7","author":"Yamamoto","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2018.09.004_bb0190","doi-asserted-by":"crossref","first-page":"e26358","DOI":"10.1371\/journal.pone.0026358","article-title":"Benefitfrom B- lymphocyte depletion using the anti-CD20 antibody rituximab in chronicfatigue syndrome. A double- blind and placebo-controlled study","volume":"6","author":"Fluge","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2018.09.004_bb0195","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.autrev.2018.03.003","article-title":"Optimizing conventional DMARD therapy for Sj\u00f6gren's syndrome","volume":"5","author":"van der Heijden","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.09.004_bb0200","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.2014.7682","article-title":"Effects of Hydroxychloroquine on symptomatic improvement in primary Sj\u00f6gren syndrome the JOQUER randomized clinical trial","volume":"312","author":"Gottenberg","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.autrev.2018.09.004_bb0205","first-page":"522","article-title":"New insights into mechanisms of therapeutic effects of antimalarial agents in SLE","volume":"8","author":"Wallace","year":"2012","journal-title":"Nat Publ Gr"},{"key":"10.1016\/j.autrev.2018.09.004_bb0210","first-page":"375","article-title":"The effect of hydroxychloroquine therapy on serum levels of immunoregulatory molecules in patients with systemic lupus erythematosus","volume":"21","author":"Wallace","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2018.09.004_bb0215","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/rheumatology\/keh506","article-title":"Hydroxychloroquine therapy in patients with primary Sj\u00f6gren's syndrome may improve salivary gland hypofunction by inhibition of glandular cho linesterase","volume":"44","author":"Dawson","year":"2005","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2018.09.004_bb0220","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1136\/annrheumdis-2012-202552","article-title":"MxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sj\u00f6gren's syndrome","volume":"73","author":"Maria","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2018.09.004_bb0225","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1002\/art.11311","article-title":"Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjogren's syndrome","volume":"48","author":"Salomonsson","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.09.004_bb0230","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.clim.2005.06.016","article-title":"Distinct profiles of Sjogren's syndrome patients with ectopic salivary gland germinal centers revealed by serum cytokines and BAFF","volume":"117","author":"Szodoray","year":"2005","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2018.09.004_bb0235","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1136\/ard.62.2.168","article-title":"The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjogren's syndrome","volume":"6","author":"Mariette","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2018.09.004_bb0240","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.autrev.2015.03.004","article-title":"Clinical picture, outcome and predictive factors of lymphoma in Sj\u04e7gren syndrome","volume":"14","author":"Papargeorgiou","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.09.004_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161226","article-title":"Serum BAFF and APRIL levels, T-lymphocyte subsets, and Immunoglobulins after B-cell depletion using the monoclonal anti-CD20 antibody rituximab in Myalgic Encephalopathy\/Chronic Fatigue Syndrome","volume":"11","author":"Lunde","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2018.09.004_bb0250","first-page":"1436","article-title":"Evaluating the functional impact of dry eye: the Ocular Surface Disease Index (Abstract)","volume":"31","author":"Walt","year":"1997","journal-title":"Drug Inf J"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997218302933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997218302933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:14:48Z","timestamp":1761599688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997218302933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S1568997218302933"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2018.09.004","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel Sj\u00f6gren's autoantibodies found in fibromyalgia patients with sicca and\/or xerostomia","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2018.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}